-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
Predictive Oncology Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from 2013 to 2023.
- Predictive Oncology Inc. Amortization of Intangible Assets for the quarter ending June 30, 2024 was $6.86K, a 2.45% decline year-over-year.
- Predictive Oncology Inc. Amortization of Intangible Assets for the twelve months ending June 30, 2024 was $27.5K, a 87.6% decline year-over-year.
- Predictive Oncology Inc. annual Amortization of Intangible Assets for 2023 was $27.4K, a 93.4% decline from 2022.
- Predictive Oncology Inc. annual Amortization of Intangible Assets for 2022 was $415K, a 10.8% increase from 2021.
- Predictive Oncology Inc. annual Amortization of Intangible Assets for 2021 was $374K, a 19.3% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Annual (USD)
Amortization of Intangible Assets, YoY Annual Growth (%)